BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Allison M. Bell, Jamie L. Wagner, Katie E. Barber, Kayla R. Stover. Elbasvir/Grazoprevir: A Review of the Latest Agent in the Fight against Hepatitis CInternational Journal of Hepatology 2016; 2016: 1 doi: 10.1155/2016/3852126
2
Mohamed A. Daw, Abdallah El-Bouzedi, Mohamed O. Ahmed, Aghnyia A. Dau, Mohamed M. Agnan. Epidemiology of hepatitis C virus and genotype distribution in immigrants crossing to Europe from North and sub-Saharan AfricaTravel Medicine and Infectious Disease 2016; 14(5): 517 doi: 10.1016/j.tmaid.2016.05.020
3
Naiema K. Ali, Ragaa R. Mohamed, Bothina E. Saleh, Manal M. Alkady, Eman S. Farag. Occult hepatitis C virus infection among haemodialysis patientsArab Journal of Gastroenterology 2018; 19(3): 101 doi: 10.1016/j.ajg.2018.09.001
4
Ali Jibran Mecci, Michelle Cheung. eLS2017; : 1 doi: 10.1002/9780470015902.a0024786
5
Dalia Omran, Mohamed Alboraie, Rania A Zayed, Mohamed-Naguib Wifi, Mervat Naguib, Mohamed Eltabbakh, Mohamed Abdellah, Ahmed Fouad Sherief, Sahar Maklad, Heba Hamdy Eldemellawy, Omar Khalid Saad, Doaa Mohamed Khamiss, Mohamed El Kassas. Towards hepatitis C virus elimination: Egyptian experience, achievements and limitationsWorld Journal of Gastroenterology 2018; 24(38): 4330-4340 doi: 10.3748/wjg.v24.i38.4330
6
G. Sanchez Antolin, M. Testillano, J.M. Pascasio, I. Narvaez Rodriguez, M. Prieto, A. Otero, J.I. Herrero, M. Londoño, I. Fernandez Vazquez, L. Castells, Xavier Xiol, Maria Luisa Gonzalez Dieguez, Mario Romero Cristobal, Jose Antonio Pons Miñano, Sonia Pascual Bartolome, Jose Luis Montero, Ana Arencibia, Sara Lorente, Esther Molina, Maria Dolores Espinosa, Valentin Cuervas-Mons, Emilio Fabrega Garcia. Efficacy and Safety of Therapy With Simeprevir and Sofosbuvir in Liver Transplant Recipients Infected by Hepatitis C Virus Genotype 4: Cohort Spanish Society of Liver Transplantation CohortTransplantation Proceedings 2016; 48(9): 3013 doi: 10.1016/j.transproceed.2016.08.034
7
Youssef M. Mosaad, Shereen S. Metwally, Raghda E. Farag, Zakeria F. Lotfy, Hosam E. AbdelTwab. Association between Toll-Like Receptor 3 (TLR3) rs3775290, TLR7 rs179008, TLR9 rs352140 and Chronic HCVImmunological Investigations 2019; 48(3): 321 doi: 10.1080/08820139.2018.1527851
8
Moataz M. Sayed, Ahmed I. El-Shafie, Ahmed Fathy Hilal, Hoda A. Abdelsattar. Can hepatitis C virus core antigen be used as a reliable marker of viral load for hepatitis C virus infection in genotype 4?Egyptian Liver Journal 2017; 7(1 and 2): 1 doi: 10.1097/01.ELX.0000523559.96944.09
9
Andréa Monteiro Tarragô, Grenda Leite Pereira, Flamir da Silva Victória, Adriana Malheiro Alle Marie, Marilú Barbieri Victória. Sofosbuvir and daclatasvir combination therapy for current hepatitis C virus genotype 4 achieves SVR: a case report of HCV genotype 4 from the AmazonRevista da Sociedade Brasileira de Medicina Tropical 2017; 50(6): 861 doi: 10.1590/0037-8682-0094-2017
10
Sevin Kirdar, Neriman Aydin, Yasin Tiryaki, Bulent Ertugrul, Adil Coskun, Mehmet Bilgen. Dynamics of HCV epidemiology in Aydin province of Turkey and the associated factorsAPMIS 2018; 126(2): 109 doi: 10.1111/apm.12790
11
Andres Tabernilla, Ignacio Rego-Pérez, Marta Grandal, Berta Pernas, Sonia Pértega, Manuel Delgado, Ana Mariño, Hortensia Álvarez, Alvaro Mena, Iria Rodríguez-Osorio, Jose Domingo Pedreira, Francisco Javier Blanco, Eva Poveda. Brief ReportJAIDS Journal of Acquired Immune Deficiency Syndromes 2016; 73(2): 149 doi: 10.1097/QAI.0000000000001097
12
Gadissa Bedada Hundie, V. Stalin Raj, Daniel GebreMichael, Suzan D. Pas, Bart L. Haagmans, Jason Blackard. Genetic diversity of hepatitis C virus in EthiopiaPLOS ONE 2017; 12(6): e0179064 doi: 10.1371/journal.pone.0179064
13
Ahmed Nagaty, Ekram W. Abd El-Wahab, Tatsuo Kanda. Real-life results of sofosbuvir based therapy in chronic hepatitis C -naïve and -experienced patients in EgyptPLOS ONE 2017; 12(10): e0184654 doi: 10.1371/journal.pone.0184654
14
Mohamed Aboushady, Ahmed Alwassief, Mohamed Abdelrazik, Dina Ziada, Hossam Shahba, Amr Elmestikawy, Ashraf Elbahrawy. Retreatment of Egyptian Chronic Hepatitis C Patients Not Responding to Pegylated Interferon and Ribavirin Dual TherapyJournal of Interferon & Cytokine Research 2019; 39(9): 539 doi: 10.1089/jir.2019.0041
15
Patrick L. Iversen. Molecular Basis of Resilience2018; : 19 doi: 10.1007/978-3-319-98164-2_2
16
Radwa R. El-Tahan, Ahmed M. Ghoneim, Hosam Zaghloul. 5′ UTR and NS5B-based genotyping of hepatitis C virus in patients from Damietta governorate, EgyptJournal of Advanced Research 2018; 10: 39 doi: 10.1016/j.jare.2018.01.004
17
Ehab H. Mattar, Hussein A. Almehdar, Vladimir N. Uversky, Elrashdy M. Redwan. Virucidal activity of human α- and β-defensins against hepatitis C virus genotype 4Molecular BioSystems 2016; 12(9): 2785 doi: 10.1039/C6MB00283H
18
Anne Boerekamps, Thomas Vanwolleghem, Marc van der Valk, Guido E. van den Berk, Marjo van Kasteren, Dirk Posthouwer, Anthonius S.M. Dofferhoff, Bart van Hoek, Dewkoemar Ramsoekh, Jelle Koopsen, Janke Schinkel, Eric Florence, Joop E. Arends, Bart J. Rijnders. 8 weeks of sofosbuvir/ledipasvir is effective in DAA-naive non-cirrhotic HCV genotype 4 infected patients (HEPNED-001 study)Journal of Hepatology 2019; 70(3): 554 doi: 10.1016/j.jhep.2018.10.032
19
G. Camus, B. Han, T. Asselah, D. Hsieh, H. Dvory-Sobol, J. Lu, E. Svarovskaia, R. Martin, B. Parhy, M. D. Miller, D. M. Brainard, K. Kersey, A. Abergel, H. Mo. Resistance characterization of ledipasvir and velpatasvir in hepatitis C virus genotype 4Journal of Viral Hepatitis 2018; 25(2): 134 doi: 10.1111/jvh.12795
20
Nicola Coppola, Loredana Alessio, Lorenzo Onorato, Caterina Sagnelli, Margherita Macera, Evangelista Sagnelli, Mariantonietta Pisaturo. Epidemiology and management of hepatitis C virus infections in immigrant populationsInfectious Diseases of Poverty 2019; 8(1) doi: 10.1186/s40249-019-0528-6
21
Rania H. Khalifa, Rasha Mohamad Hosny Shahin, Reham Emad Eldin Aboukhalil, Mohamed A. Marie, Amr M. El-deeb, Nermine Magdi Riad. Digging more in the genetic risk prediction of hepatitis C virus epidemic in Egypt: Apoptosis genes polymorphisms in the susceptibility of hepatitis C virus and association with viral loadVirus Research 2017; 238: 35 doi: 10.1016/j.virusres.2017.05.025